CD106 is a novel mediator of bone marrow mesenchymal stem cells via NF-κB in the bone marrow failure of acquired aplastic anemia

CD106 is a novel mediator of bone marrow mesenchymal stem cells via NF-κB in the bone marrow failure of acquired aplastic anemia

Abstract Background Acquired aplastic anemia (AA) is characterized by deficiency or dysfunction of the bone marrow (BM) microenvironment. However, little is known about the impairment of BM-derived mesenchymal stem cells (MSCs) in AA patients. Methods We used Illumina HiSeqTM 2000 sequencing, quanti...

Full description

Bibliographic Details
Main Authors: Shihong Lu, Meili Ge, Yizhou Zheng, Jianping Li, Xiaoming Feng, Sizhou Feng, Jinbo Huang, Ying Feng, Donglin Yang, Jun Shi, Fang Chen, Zhongchao Han
Format: Article
Language:English
Published: BMC 2017-08-01
Series:Stem Cell Research & Therapy
Subjects:
Aplastic anemia
Mesenchymal stem cells
CD106
hematopoiesis
Online Access:http://link.springer.com/article/10.1186/s13287-017-0620-4

Internet

http://link.springer.com/article/10.1186/s13287-017-0620-4

Similar Items